VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 0960350
Sex: F
Age:
State: GA

Vax Date: 12/17/2020
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache for the entire day; Malaise; Fatigue; Body aches; Vivid dreams (fever); Vivid dreams (fever); This is a spontaneous report from a contactable nurse. This 41-year-old female nurse (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=Ej1685), via unspecified route at left arm on 17Dec2020 07:30 PM at single dose for COVID-19 immunization. Medical history included Insomnia and obesity. No known allergies. No other vaccine in four weeks. Concomitant medications included zolpidem tartrate (AMBIEN), acetaminophen, acetylsalicylic acid (ASPIRIN) and diphenhydramine. On 08Jan2021, patient experienced headache for the entire day, malaise and fatigue, body aches and vivid dreams (fever), all with outcome of recovered in Jan2021. No treatment was received. No COVID prior vaccination. No COVID tested post vaccination.

Other Meds: AMBIEN; ACETAMINOPHEN; ASPRIN;

Current Illness:

ID: 0960351
Sex: U
Age:
State: CT

Vax Date: 12/22/2020
Onset Date: 12/24/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; This is a spontaneous report from a contactable Other HCP. This Other HCP reported for self that the 54-year-old patient of unknown gender received first dose of bnt162b2 (BNT162B2), via Intramuscular on 22Dec2020 05:00 PM on Left arm at a single dose for covid-19 immunisation. Medical history included Known allergies: Zithromax. No other vaccine in four weeks. Concomitant medication included in two weeks sertraline hydrochloride (ZOLOFT). The patient reported "48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums. I have never had any of these symptoms at any other time in my life". The events started from 24Dec2020 07:00 PM. The outcome of the events was recovered. No treatment was received. No COVID prior vaccination. COVID tested post vaccination: covid test type post vaccination was Nasal Swab on 09Jan2021 with covid test result of Negative. Information on the Lot/Batch Number has been requested.

Other Meds: ZOLOFT

Current Illness:

ID: 0960352
Sex: F
Age:
State: KS

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; fever (Tmax 102.7F despite acetaminophen use); body/muscle aches; body/muscle aches; significant headache; fatigue; first dose on 16Dec2020 13:00/second dose on 05Jan2021 12:45; first dose on 16Dec2020 13:00/second dose on 05Jan2021 12:45; This is a spontaneous report from a contactable physician (patient). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via an unspecified route of administration at left arm on 05Jan2021 12:45 at single dose for COVID-19 immunization. Medical history included seasonal allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (lot number: EH9899) via an unspecified route of administration at left arm on 16Dec2020 13:00 at single dose for COVID-19 immunization. Approximately 9 hours following the second dose (reported as 05Jan2021 22:30) patient started with chills and fever (Tmax 102.7F despite acetaminophen use), then significant body/muscle aches, significant headache, fatigue. Symptoms lasted 24hrs from that time. Fatigue lasted 36-48hrs. Patient received home use of acetominophen, Ibuprofen, Nurtec as treatment. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0960353
Sex: M
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Injections site pain; Myalgia; Malaise; This is a spontaneous report from a non-contactable physician (patient). A 27-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 09Jan2021 16:00 at single dose for COVID-19 immunization. Medical history was reported as none and no known allergies. The patient's concomitant medications were not reported. The historical vaccine included first dose of BNT162B2 intramuscular at left arm on 19Dec2020 16:00 for COVID-19 immunization. The patient experienced headache, injections site pain, myalgia, malaise on 10Jan2021 09:00 with outcome of recovering. No treatment received for the adverse events. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960354
Sex: M
Age:
State: GA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Uncontrollable rigors; profound fatigue; weakness; achiness; nausea; fever (up to about 102).; This is a spontaneous report from a contactable physician reporting for himself. A 51-year-old male patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL3246, expiry date not reported) on 09Jan2021 at 08:30 via an unspecified route of administration in the left arm for COVID-19 immunization. The patient's medical history included penicillin allergy. No other medical history. The patient had not had COVID prior to the vaccination and had not been tested post the vaccination. The patient had received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1685, expiry date not reported) on 19Dec2020 at 16:30 via an unspecified route of administration in the left arm for COVID-19 immunization. No other vaccine received in four weeks. Concomitant medication included paracetamol (TYLENOL). On 09Jan2021 at 23:30, the patient experienced uncontrollable rigors, profound fatigue, weakness, achiness, nausea, fever (up to about 102). The events were non-serious. The patient took over the counter paracetamol (TYLENOL) and ibuprofen for the events, and was recovering from the events.

Other Meds: TYLENOL

Current Illness:

ID: 0960355
Sex: F
Age:
State: KY

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe nausea/vomiting 4 days after receiving vaccine; Severe nausea/vomiting 4 days after receiving vaccine; This is a spontaneous report from a contactable other HCP reporting for herself. A 34-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 06Jan2021 at 09:15 at single dose intramuscular in left arm for COVID-19 immunisation. The patient had no relevant medical history and was not receiving concomitant medications. The patient had no known allergies. The patient was vaccinated at hospital. Patient age at time of vaccination was 34 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior to vaccination and was not COVID tested post vaccination. The patient experienced 'severe nausea/vomiting 4 days after receiving vaccine' (as reported) with onset date on 09Jan2021 at 11:00 PM. The patient received treatment for the events with promethazine. The events resolved on an unspecified date in Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960356
Sex: F
Age:
State: PA

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; tachycardia; This is a spontaneous report from a contactable Other HCP (patient). A 37-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EJ1685, via unspecified route of administration in the arm left on 22Dec2020 at single dose for COVID-19 immunization. Patient medical history included pituitary gland tumor, kidney stones, binge eating disorder and unspecified allergy (known allergies: Yes). Patient was not pregnant. Concomitant medications were not reported. The patient experienced dizziness and tachycardia on 22Dec2020. No treatment was given for the events. Outcome of events was recovered on unspecified date.

Other Meds:

Current Illness:

ID: 0960357
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; cough; This is a spontaneous report from a contactable nurse reporting for herself. A 25-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), via an unspecified route of administration on 07Jan2021 at single dose in right arm, for COVID-19 immunisation. Age at vaccination was 25 years. The patient has known allergies to avocado and amoxicillin. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EJ1685) received on 17Dec2020. The patient did not have COVID prior to vaccination and was not COVID tested post vaccination. The patient's concomitant medications were not reported. On 08Jan2021 at 08:00 PM the patient experienced headache and cough. No treatment was received for the events. The events were resolving.

Other Meds:

Current Illness:

ID: 0960358
Sex: F
Age:
State: MA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low grade fever; chills; muscle weakness; First dose received on 19Dec2020 second dose received on 08Jan2021; First dose received on 19Dec2020 second dose received on 08Jan2021; This is a spontaneous report from a contactable pharmacist (patient). A 43-year-old female patient not pregnant received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 08Jan2021 (unapproved schedule) as a single dose for COVID-19 immunization, lot number: EL3302. Medical history was reported as none. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. First vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 Intramuscular Left arm, lot number: EK5730. On 09Jan2021 patient experienced low grade fever, chills, muscle weakness. No treatment received for the events. Patient was tested for Covid post vaccination with Nasal Swab on 06Jan2021 result was negative. Patient was recovering from the events, at the time of the report. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960359
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flushed face; Severe nausea; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 11Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included hypertension and gastrooesophageal reflux disease. The patient previously took lisinopril and experienced drug hypersensitivity and anaphylactic reaction, diphenhydramine (BENADRYL) and experienced drug hypersensitivity and urticaria. Concomitant medication included propranolol hydrochloride (PROPRANOL), chlorthalidone (unknown manufacturer), rabeprazole sodium (ACIPHEX), vitamin c (unknown manufacturer). The patient experienced flushed face and severe nausea on 11Jan2021 13:00 with outcome of not recovered. It was unknown f treatment was performed. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19. Information on the Batch/Lot number has been requested.

Other Meds: PROPRANOL; CHLORTHALIDONE; ACIPHEX; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 0960360
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; vomiting; headache; fever; malaise; muscle pain; chills; This is a spontaneous report from a contactable Other-health care professional (HCP) (patient). A 35-year-old female patient not pregnant received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Intramuscularly in the Left arm on 08Jan2021 04:00 PM as a single dose for COVID-19 immunization, lot number: unknown. Medical history was reported as none. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. Patient had not been tested for COVID-19 post vaccination. On 09Jan2021 08:00 AM, patient experienced nausea, vomiting, headache, fever, malaise, muscle pain, chills. No treatment received for the events. Patient recovered from the events on unknown date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960361
Sex: F
Age:
State: OK

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: inappropriate schedule of vaccine administered (first dose on 18Dec2020, second dose on 07Jan2021); Temp 102; body aches; chills; lymph node in right armpit swelling sz golf ball; vertigo all lasted 2.5 days; migraine pain >10 on pain scale; rash on hands and arms; nausea; blurred vision; Ongoing headache and body aches 5 days now; This is a spontaneous report from a contactable Nurse (patient). A 50-year-old Female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 07Jan2020 at 09:00 a.m. intramuscular on right arm at single dose for COVID-19 immunization. Relevant medical history included hypothyroidism, post-traumatic stress disorder, anxiety and allergy to tetracycline. Concomitant medications included escitalopram oxalate (LEXAPRO), celecoxib (CELEBREX), levothyroxine, esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]), colecalciferol (VITAMIN D [COLECALCIFEROL]) and paracetamol (TYLENOL). The patient received first dose of BNT162B2 on 18Dec2020 at 04:00p.m. intramuscular on right arm. On 07Jan2021 at 11:00 a.m. the patient experienced pyrexia with temperature of 102, body aches, chills, lymph node in right armpit swelling sz golf ball (as reported), nausea, migraine pain >10 on pain scale (as reported), rash on hands and arms, blurred vision and headache. On 08Jan2021 the patient underwent Nasal Swab SARS-CoV-2 test (Abbott) which resulted negative. No Treatment received for events. The patient recovered from vertigo on 09Jan2021. At the time of the reporting the patient had not yet recovered from headache and body aches, while was recovering from other reported events. Information about Lot/Batch number has been requested.

Other Meds: LEXAPRO; CELEBREX; ; NEXIUM [ESOMEPRAZOLE SODIUM]; VITAMIN D [COLECALCIFEROL]; TYLENOL

Current Illness:

ID: 0960362
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; lightheaded and kind of dizzy; Her stomach doesn't feel great ("stomach isn't the best"); Dry mouth; nausea; This is a spontaneous report from a contactable consumer (patient). This 88-year old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021, for COVID-19 immunization. Medical history and concomitant medications were not reported. On 09Jan2021 the patient experienced sore arm. Since an unspecified date in Jan2021 she was lightheaded and kind of dizzy, her stomach did not feel great, she had dry mouth and nausea. She was feeling as if she could get sick (further specified as nausea). She had not got sick but her stomach wasn't the best. Events outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960363
Sex: M
Age:
State:

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: right eye has little shooting lightning bolts that are constant; This is a spontaneous report from a contactable other healthcare professional (patient) through the Medical Information Team. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on 11Jan2021 11:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that at 11:30am he received the Covid vaccine and now his right eye had little shooting lightning bolts that were constant. He wanted to know if that was a common side effect. Outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960364
Sex: F
Age:
State: FL

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lymph node under her tongue on the left side of her jaw that is swollen; sore throat; left jaw is swollen; arm is sore; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown), via an unspecified route of administration on 10Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that her arm is sore on 10Jan2021, but everything else was fine until on 11Jan2021, she went into the bathroom and it felt a little funny under her tongue. Under her tongue, her left jaw is swollen, like visibly swollen on the left side and her lymph node under her tongue, but just on the left side. She reported that her throat is a little sore too. She was wondering if these are known side effects of the product, because she is trying to decide if she needs to just let it go or wait and see. Outcome of the events was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0960365
Sex: M
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; tiredness; muscle pain; chills/shaking in bed with blanket on; still get wet/sweat; headache; nausea; feeling unwell; Felt "very sick"; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on 06Jan2021, at 76 years of age, at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 06Jan2021, 45 minutes after shot, the patient felt "very sick" and was on bed for 4 days; moreover the patient reported he had "a big reaction" as, on an unspecified date, he felt fever, tiredness, muscle pain, chills (reported as "shaking in bed with blanket on"), still get wet/sweat, headache, nausea and feeling unwell. All the reported events were assessed as non-serious. At the time of the report the events "felt very sick", "tiredness", "muscle pain", "chills/shaking in bed with blanket on" and "still get wet/sweat" had resolved on an unspecified date, the events "fever", "headache" had not resolved yet and outcome of the events "nausea" and "feeling unwell" was unknown. The patient asked whether or not to take the 2nd shot in 3 weeks. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960366
Sex: F
Age:
State: PA

Vax Date: 12/30/2020
Onset Date: 01/02/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chest and axillary adenopathy; Tender clavicular; This is a spontaneous report from contactable healthcare professional (patient). This 45-year-old female patient (non-pregnant) received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot 9231) intramuscular, in left arm, on 30Dec2020 at 17:45, for COVID-19 immunization. No other vaccine was given in 4 weeks. Medical history included allergy to sulfamethoxazole (BACTRIM). The patient had no COVID19 prior vaccination and was not tested after vaccination. Concomitant medication included ethinylestradiol, levonorgestrel (DAYSEE) 0.15-0.03 (unspecified unit and frequency). On 02Jan2021 the patient experienced chest and axillary adenopathy and tender clavicular. No treatment was given. The events had not yet resolved at the time of report.

Other Meds: DAYSEE

Current Illness:

ID: 0960367
Sex: F
Age:
State: NY

Vax Date: 12/22/2020
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: positive Covid test the day before second dose of vaccine; positive Covid test the day before second dose of vaccine; This is a spontaneous report from a Pfizer-sponsored program, by contactable physician reported for herself. This 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EK5730), intramuscular at single dose in the left deltoid on 22Dec2020 11:00 for Covid-19 immunisation. Medical history included was none. There were no concomitant medications. The patient experienced positive Covid test the day before second dose of vaccine on 11Jan2021 with outcome of not recovered. On an unspecified date, she can't smell or taste and has some shortness of breath on exertion with outcome of unknown. No further treatments given. Did not have any antibody testing recently and had history of negative antibodies prior to everything, receiving the first vaccine. The vaccine was administered at Hospital Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first vaccine on 22Dec2020 and went for Covid testing on Saturday, 09Jan2021. Found out results were positive on 11Jan2021. She was scheduled to have the second Covid vaccine on 12Jan2021. Patient then asks if there is a problem with her getting the second dose vaccine 10 days later than originally scheduled due to her results.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be completely excluded for reported "positive Covid test the day before second dose of vaccine".

Other Meds:

Current Illness:

ID: 0960368
Sex: F
Age:
State: CA

Vax Date: 12/21/2020
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lymphadenopathy at her bilateral axilla.; This is a spontaneous report from a contactable pharmacist (patient). This pharmacist reported similar events for 2 patients. This is the first report out of 2 patients. Only this case is serious, medically significant. A 33-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot EK5730, expiry date: 31Mar2021, NDC number: 59267-1000-1), intramuscular in the left deltoid on 21Dec2020 17:32 at 0.3ml single, for Covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced lymphadenopathy at her bilateral axilla and got worse on 07Jan2021. She reported that it was painful and swollen. The events was reported as serious medically significant. She wanted to know if she should have the 2nd dose of the vaccine. The outcome of the event was not recovered.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported lymphadenopathy cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : 2021025446 same reporter and drug/similar event/different patients

Other Meds:

Current Illness:

ID: 0960369
Sex: F
Age:
State: SC

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a mild anaphylactic reaction; tongue numbness/lips and tongue started to get numb; throat swelling; she was getting a migraine; she was flushed and her head got sick, and she got congested; she was flushed and her head got sick, and she got congested; she was flushed and her head got sick, and she got congested; This is a spontaneous report from a contactable other health professional (patient). This female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EK5730, Expiry Date Mar2021), via an unspecified route of administration at single dose in the left arm on 28Dec2020 for Covid-19 immunisation. Medical history included allergies to beestings. There were no concomitant medications. On an unspecified date, the patient experienced a mild anaphylactic reaction, tongue numbness, she was getting a migraine, throat swelling, she was flushed and her head got sick, and she got congested. No treatment required. The outcome of the events was recovered. The events were described as follows: Patient stated that she took the first dose of the Pfizer vaccine on 28Dec2020. She had an immediate reaction where she was thinking that she was getting a migraine; those symptoms included that the room got loud, she was flushed and her head got sick, and she got congested. She works at a hospital, and she got the vaccine at that hospital where she works. She waited the standard 15 minutes after the injection and then she walked back to her office. After 25 minutes had passed after getting the vaccine, her lips and tongue started to get numb and she could feel like her throat was starting to swell. Se did not take Benadryl, although in hindsight, she should have. She does have allergies to beestings, but the people administering the product did not know that. The primary care physician said that he did not think that she should take the second dose.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of mild anaphylactic reactions cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product. Severe allergic reaction is the known risk for the product. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960370
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: developing "hives" 36 hours post injection; This is a spontaneous report from a contactable pharmacist. A female patient (Age: 38; unit: unknown) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 08Jan2021 at a single dose for covid-19 immunization. Medical history included COVID-19 o 30Oct2020, developing "rashes anytime [she] gets ill" and she therefore believes that her reaction was her immune system's response. The patient's concomitant medications were not reported. The patient developed "hives" 36 hours post injection on Jan2021 with outcome of unknown. She asked if such "delayed" reaction was reported as a side effect of the vaccine. mentioned that she would like to receive the second dose, although her PCP is reluctant to it. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0960371
Sex: F
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; chills; body aches; Vomited; This is a spontaneous report from a contactable consumer (Parent). A 23-year-old female patient not pregnant received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 08Jan2021 08:00 AM as a single dose for COVID-19 immunization, lot number: EL1283. Medical history was reported as none. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. First vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 03:30 PM via an unspecified route of administration in the Left arm lot number: EK5730. It was reported that on 08Jan2021 at 04:00 PM, after second vaccine dose that was administered at 8:00 am, patient vomited at 4:00 pm. On 09Jan2021 at 3:30 am woke up with fever, chills and body aches. No treatment received for the events. Patient was not tested for Covid post vaccination. Patient recovered from all the reported events, at the time of the report.

Other Meds:

Current Illness:

ID: 0960372
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have a major side sore arm, soreness has gotten better, it has developed into a bump on the site of the injection; I have a major side sore arm, soreness has gotten better, it has developed into a bump on the site of the injection; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at a single dose as a COVID-19 vaccine. The patient's medical history and concomitant medications were not reported. The patient stated that she had a major side sore arm, but the soreness has gotten better. It had developed into a bump on the site of the injection. She was not sure if it's swelling. Stated that it's still there. The patient was asking if this was normal and how long it will take. Outcome of the event pain in arm was recovering, while for the event vaccination site mass was not recovered. Information about the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0960373
Sex: F
Age:
State: NM

Vax Date: 01/02/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a redness and swelling appeared around the injection spot; a redness and swelling appeared around the injection spot; itchy; This is a spontaneous report from a contactable healthcare professional (patient herself) and consumer. A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 02Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant and had not tested positive for COVID prior vaccination. On 11Jan2021 07:30AM, 9th day after the vaccination, a redness and swelling appeared around the injection spot, as a round region of 2.5'' in diameter. One spot inside this round region was very itchy. A much smaller region of redness was seen during the first two days but disappeared on the 3rd day and reappeared as described above. No treatment was received for the events and the outcome was not recovered. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960374
Sex: F
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: couldn't remember passcode for the phone or her address; feeling heavy; chills; headache; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration first dose on 10Jan2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that after receiving her Covid19 vaccine on Sunday 10Jan2021, reports feeling "heavy", chills, and a headache on Sunday 10Jan2021. On 11Jan2021 Monday afternoon she reports that she "couldn't remember the 4-digit passcode to my phone" or her address, but that her memory came back "in a second". The event couldn't remember passcode for the phone or her address was reported as recovered and unknown for the other events. Information on the Lot/Batch number has been requested

Other Meds:

Current Illness:

ID: 0960376
Sex: F
Age:
State: TX

Vax Date: 12/19/2020
Onset Date: 12/20/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching; palpitations; back ache; had an allergic reaction; full blown hives; rash on her face, ears, legs and arms; fever; tired; sore throat; swollen lymph nodes; chills; This is a spontaneous report from a contactable nurse (patient) via a Pfizer-sponsored program. A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EJ1685, expiry: Mar2021) intramuscularly on 19Dec2020 at a single dose for covid-19 immunisation. Medical history was reported as none. The patient's concomitant medications were not reported. On 20Dec2020, the patient experienced fever, tired, sore throat, swollen lymph nodes and chills. On 08Jan2021, the patient experienced rash on her face, ears, legs and arms. On 09Jan2021, the patient had an allergic reaction and had full blown hives. It was also reported that the patient experienced itching and back ache on an unspecified date. The patient also experienced palpitation on an unspecified date and she went to the emergency room in which she was prescribed with lorazepam (ATIVAN). The patient was also treated with naproxen (ALEVE) for fever and back ache, steroid (unspecified) for allergic reaction and hives, TRIAMCINOLONE cream for the rash and HYDROXYZINE for the itching. Outcome of the events fever, tired, sore throat, swollen lymph nodes and chills recovered on 21Dec2020 while for the events full blown hives, itching, had an allergic reaction, rash on her face, ears, legs and arms, palpitations and back ache was unknown.

Other Meds:

Current Illness:

ID: 0960377
Sex: M
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; tiredness with pain in the body; tiredness with pain in the body; This is a spontaneous report from a contactable consumer reporting for himself. A male patient of an unspecified age received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number and expiry date not reported) via an unspecified route of administration on 05Jan2021 for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fever, tiredness with pain in the body on an unspecified date in Jan2021. The events were not resolved. Information on batch/lot number was requested.

Other Meds:

Current Illness:

ID: 0960378
Sex: F
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness and tingling in hands and spread to calves and feet; numbness and tingling in hands and spread to calves and feet; This is a spontaneous report from a contactable Consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 at single dose for covid-19 immunisation. Medical history included nerve issues. The patient's concomitant medications were not reported. On 12Jan2021, the patient received vaccine and developed numbness and tingling in hands and spread to calves and feet. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960379
Sex: F
Age:
State: KS

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I felt nauseated; I experienced a severe headache the following day.; 1 dose start date 18Dec2020; 2 dose start date 07Jan2021; 1 dose start date 18Dec2020; 2 dose start date 07Jan2021; This is a spontaneous report from a contactable other health professional (patient). A 47-year-old female patient (pregnant: No) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number/expiration date unknown) via intramuscular on 07Jan2021 02:45 PM (vaccine location: Right arm) at a single dose for COVID-19 immunization. Previous vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number/expiration date unknown) via intramuscular on 18Dec2020 02:30 PM (vaccine location: Right arm) at a single dose for COVID-19 immunization. Medical history were not reported. The concomitant included Multi-vitamin, 2 naproxen sodium (ALEVE) the day of the 2nd dose of the vaccine (07Jan2021). No other vaccine in four weeks. Patient experienced a severe headache the following day (08Jan2021). On Saturday, 09Jan2021 patient felt nauseated. No treatment given for severe headache and nauseated. The outcome of the events, severe headache and nauseated was recovered in Jan2021. Information on lot/batch number has been requested.

Other Meds: ALEVE

Current Illness:

ID: 0960380
Sex: M
Age:
State: CA

Vax Date: 01/10/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: he keeps throwing up and it's just mucus; This is a spontaneous report from a Pfizer sponsored program Pfizer First Connect. A contactable consumer (patient's daughter) reported for her father that an 87-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, on 10Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient's daughter said her father has been vaccinated today 10Jan2021 for the 1st dose, and he kept throwing up and it's just mucus since an unspecified date in Jan2020. Outcome of the event was unknown. Information on Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0960381
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had a temperature of 102 broke a fever; couldn't get out of bed/weak; chills; bad body ache; couldn't sleep the whole night; This is a spontaneous report from a contactable other HCP repot for self. A 35-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 15:15 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received the first dose of BNT162B2 at 35-year-old on 15Dec2020 and experienced sore arms, no other symptoms. After the 2nd dose patient was ok until got home around 9pm roughly 6 hours later, patient had chills and bad body ache. She couldn't sleep the whole night. In the morning (on 09Jan2021) she had a temperature of 102 broke a fever, couldn't get out of bed until the morning 24 hours later, she was really weak. Patient don't have any comorbidities, she was generally a healthy 35 year old person, no other health issues. Now patient feel like back to normal. The outcome of events was recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960383
Sex: F
Age:
State: IL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site pain; feeling feverish; This is a spontaneous report from a contactable nurse reported for herself. This 51-year-old female patient (No pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1283), via an unspecified route of administration in right arm on 07Jan2021 at single dose for COVID-19 immunization. Medical history included childhood asthma, Type 2 diabetes mellitus (NIDDM), Latex allergies. Concomitant medication included Metformin, Glyburide, Lisinopril, empagliflozin (JARDIANCE), sitagliptin (JANUVIA), Atorvastatin, salbutamol (PROVENTIL), fluticasone propionate, salmeterol xinafoate (ADVAIR), paracetamol (TYLENOL), colecalciferol (D3), Diosmin, Niacin, fluticasone propionate (FLONASE), ascorbic acid (VIT C), MVI. Patient received first dose of BNT162B2 intramuscular in left arm on 17Dec2020 02:45 PM and experienced injection site pain, increased soreness in 24 hrs, Bleeding at left arm injection site, Flu like symptoms at the 12th hour of vaccination, feeling unwell, fatigue, mild headache. After the second dose on 07Jan2021, the patient experienced injection site pain and feeling feverish the first hour. The outcome of events was unknown. No COVID prior vaccination, no COVID tested post vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds: ; GLYBURIDE; ; JARDIANCE; JANUVIA [SITAGLIPTIN]; ; PROVENTIL [SALBUTAMOL]; ADVAIR; TYLENOL; D3; ; NIACIN; FLONASE [FLUTICASONE PROPIONATE]; VIT C; MVI [ASCORBIC ACID;DEXPANTHENOL;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETIN

Current Illness:

ID: 0960384
Sex: F
Age:
State: TX

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Muscle aches; General unwell; Anxiety; Body feels heavy and hard to move; Body feels heavy and hard to move; Arm where injected is very uncomfortable; This is a spontaneous report from a contactable nurse (patient). A 30-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration on 12Jan2021 at a single dose on left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Zk5730), via an unspecified route of administration on 22Dec2020 at a single dose on left arm for COVID-19 immunization (at 29 years old). The patient experienced nausea, Muscle aches, General unwell, Anxiety, Body feels heavy and hard to move around, Arm where injected is very uncomfortable on 13Jan2021 01:30 AM. The outcome of the events was recovering. The events were assessed as non-serious. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was Hospital. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0960385
Sex: M
Age:
State: IL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left axillary lymphadenopathy; This is a spontaneous report from a contactable physician (patient). A 56-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unknown), intramuscular on the left arm on 11Jan2021 at 08:00 at a single dose for COVID-19 immunization. Medical history was reported as none. No known allergies to food, medications or other products. The patient's concomitant medications were not reported. No other vaccines received within 4 weeks prior to the COVID vaccine and no other medications received within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 via the intramuscular route at the left arm for COVID-19 Immunization on 21Dec2020 at 09:00 at the age of 56 years old. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced left axillary lymphadenopathy on 12Jan2021 at 10:00. No treatment was administered for the event. The event was resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960386
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: my arm at the injection site hurt.; couldn't move or lift arm due to the pain; couldn't move or lift arm due to the pain; This is a spontaneous report from a contactable consumer [patient]. A 32-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on an unspecified date at single dose at arm for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient woke up the night after the injection and arm at the injection site hurt. couldn't move or lift arm due to the pain. Took 400mg of ibuprofen and can move arm again. The patient was still on 400 mg ibuprofen twice a day for pain. The outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960387
Sex: F
Age:
State: MI

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; headache; Muscle pain/stiffness; Muscle pain/stiffness; This is a spontaneous report from a contactable health professional (patient). A 55-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231, vaccine location: left arm) via an unspecified route of administration on 12Jan2021 05:00 pm at hospital at single dose for COVID-19 immunization. Medical history included high blood pressure and migraine. Concomitant medication in two weeks included atenolol, furosemide, bupropion hydrochloride (WELLBUTRIN), hyoscyamine and magnesium. Patient had not had COVID-19 prior vaccination. Patient had not been tested for COVID-19 post vaccination. The patient was not pregnant. No other vaccine was received in four weeks. The patient previously took first dose of bnt162b2 (lot number El0140, vaccine location: left arm) at the age of 55 years on 22Dec2020 05:15 pm for COVID-19 immunization. Known allergies included tetracycline, montelukast sodium (SINGULAIR), nifedipine, hydrochlorothiazide (HCTZ), erythromycin and sumatriptan. The patient experienced dizziness, headache, muscle pain or stiffness on 12Jan2021 06: 00 pm. No treatment was received for all events. The outcome of the events was not recovered.

Other Meds: ; ; WELLBUTRIN; ;

Current Illness:

ID: 0960388
Sex: M
Age:
State: FL

Vax Date: 12/23/2020
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ended up having a rash or allergies; Ended up having a rash or allergies; This is a spontaneous report from a contactable other health professional (patient) via a Pfizer-sponsored program Pfizer First Connect. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization, doxycycline hyclate; methylprednisolone; methylprednisolone sodium succinate (SOLU-MEDROL); amoxicillin via an unspecified route of administration from an unspecified date to an unspecified date at unknown dose and frequency for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient got his first dose on 23Dec2020, due on Tuesday for 2nd dose. No reactions when he took the first shot. The caller was taking different medicines on 10Jan2021 and ended up having a rash or allergies. Gave allergic reaction Amoxicillin, Solu Medrol injection, Doxycycline, Methylprednisolone. The patient wanted to know if he can still be able to get the 2nd dose of vaccine on Tuesday. The action taken in response to the events for doxycycline hyclate was unknown, for methylprednisolone was unknown, for methylprednisolone sodium succinate was unknown, for amoxicillin was unknown. The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0960389
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pain; sore throat; headache; This is a spontaneous report from a Pfizer-sponsored program. A contactable 43-year-old female Nurse (patient) received the first dose of BNT162B2 (Covid-19 vaccine) on an unspecific date at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Caller said she is scheduled for the 2nd dose of Covid-19 vaccine tomorrow. but she is a PUI and has to be on a covid test tomorrow. Caller wanted to know if she still had to take the 2nd dose of covid-19 vaccine, since she's still experiencing muscle pain and sore throat. Mentioned having headache also but gone now. Outcome of the event headache was recovered, for other events was not recovered. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0960390
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache (HA); Slight fever; This is a spontaneous report from a contactable consumer (father-in-law). This consumer reported similar events for two patients. This is the first of two reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date), via an unspecified route of administration, on an unspecified date at an unspecified dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced headache (HA) and slight fever on an unspecified date. The outcome of the event was unknown. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021031244 Same reporter, drug, and event, different patient

Other Meds:

Current Illness:

ID: 0960391
Sex: F
Age:
State: OR

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nausea; like a hundred temperature/high; body aches; headache; fatigue; This is a spontaneous report from a Pfizer-sponsored program. A contactable 34-year-old female patient reported she received first dose bnt162b2 (BNT162B2), via an unspecified route of administration on 06Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced like a hundred temperature/high and then nausea but no vomiting on 06Jan2021. And she's currently having body aches, and headache but no vomiting, fatigue since an unknow date in Jan2021. The patient underwent lab tests and procedures which included body temperature: like a hundred temperature/high on 06Jan2021. The patient was better now like a hundred temperature/high was recovering; nausea was not recovered; outcome of other events were unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0960392
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low testosterone; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a female patient of unknown age that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on an unknown date at single dose for COVID-19 immunization. Concomitant medications and past drug/medical history were not reported. Caller wanted to know if a patient should stop taking a medication for low testosterone after having gotten the vaccine. Outcome of event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960393
Sex: U
Age:
State: IL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a very mild cough; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, on 06Jan2021 at single dose for COVID-19 immunisation. Medical history included being exposed at home to a symptomatic COVID patient on 04Jan2021. Concomitant medications were not reported. Patient previously received first dose of BNT162B2 on 16Dec2020 for COVID-19 immunisation. Patient received the second COVID vaccine on 06Jan2021 and had a very mild cough from 06Jan2021 to 09Jan2021. Patient had PCR COVID test on 09Jan2021 and pending result. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960394
Sex: F
Age:
State:

Vax Date: 12/20/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she has a low grade fever; a swollen left node on the neck; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported for self that a female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. patient got her 1st dose last Dec2020 and is scheduled for the 2nd dose today. She mentioned she has a low grade fever and a swollen left node on the neck. She wants to know if that will contraindicate on taking the vaccine. Outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960395
Sex: M
Age:
State: MI

Vax Date: 01/09/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experiencing low-grade fever.; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored. The male patient received first dose of bnt162b2 (BNT162B2), unknown on 09Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced low-grade fever on an unspecified date. It was reported as " had the vaccine yesterday and i had like a really low-grade fever and I was wondering if it was okay to just take some Tylenol for the fever". The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0960396
Sex: M
Age:
State: PA

Vax Date: 12/21/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; fatigue; This is a spontaneous report from a contactable physician. An elderly (reported as 65+ Years) male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on 21Dec2020 (Lot number: ej1685) via an unspecified route of administration, second dose on 11Jan2021 (Lot number: e21685) via intramuscular, both at single dose for COVID-19 immunisation. Medical history included known allergies to penicillin and erythromycin. The patient's concomitant medications were not reported. The patient experienced chills and fatigue on an unspecified date. No treatment was received for adverse events. The patient received vaccine in hospital. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The outcome of events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0960397
Sex: U
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt achy and sore; clammy; This is a spontaneous report from a non-contactable nurse (patient) via Pfizer sales representative. A patient of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. Patient was vaccinated by employer. The patient's medical history and concomitant medications were not reported. The patient received first dose of bnt162b2 on an unspecified date. The patient felt achy, clammy and sore in Jan2021. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960398
Sex: M
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills/rigors; back ache; headache; temp was now 101.2; feeling really ill; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient was feeling really ill from his second vaccine shot, on 09Jan2021, he experienced chills for 12 hours, rigors, back ache, headache. First dose was only arm soreness. It was reported temp was now 101.2 (unit not provided). The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected. Information about Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960399
Sex: F
Age:
State: NJ

Vax Date: 01/10/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; Heaviness in her chest; Pulse is in the 90s; Now her temperature was 101.2 degrees F; Soreness in her left arm; Chills; Not feeling too well/flu-like feeling; Not feeling too well/flu-like feeling; Slight headache / headache; This is a spontaneous report from a contactable consumer (patient). This 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unknown route, on 10Jan2021 at 15:00 at single dose in the left arm for COVID-19 immunisation. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EZ0140) administered in the upper left arm on 20Dec2020 (at 14:45-15:00) and developed a little headache, soreness and was tired (reported under AER 2021026236). Relevant medical history included thyroid, cholesterol and blood pressure (as reported). The patient was taking concomitant medications for underlying medical history. No other vaccine was received in four weeks. In the evening yesterday she was not feeling too well. She had a slight headache; body aches and she could get rid of the headache. She clarified that last night she felt chilly, she had the chills. By 10am this morning she did not feel well, she had a pretty bad headache and felt like she had a temperature. Her temperature earlier today was 99.4 degrees F and now her temperature was 101.2 degrees F. Her whole body feels like she was having aches, stated it is like a flu-like feeling, she had heaviness in her chest, her pulse will not go out of the 90s. She took her oxygen level and it was between 97-99%. She had also soreness in her left arm. She asked if these are common side effects, or something to be concerned about. Therapeutic measures taken as result of the events included ibuprofen (ADVIL). The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0960400
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: blister at the injection site that has turned into a scab; blister at the injection site that has turned into a scab; This is a spontaneous report from a contactable other health professional (nurse practitioner). This other health professional reported similar events for three patients. This is the 3rd of three reports. A 25-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284, expiry date: 30Apr2021), intramuscular at deltoid right on 06Jan2021 at 0.3 mL at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced blister at the injection site that has turned into a scab. The patient outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0960401
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/24/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after sleeping with her neck completely craned; paresthesia in the fingers of her left hand/right paresthesia on the sole of her foot; shock-like symptoms in both hands; Fever; Malaise; This is a spontaneous report from a contactable physician (patient). A female patient of unspecified age received BNT162B2 on 22Dec2020 first dose at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. She had the first vaccination on 22Dec2020. Caller states she had a fever, malaise for 2 days afterwards (24Dec2020). Around Day 4 (26Dec2020), she developed paresthesia in the fingers of her left hand and stimulation in her left hand, there was quite a lot of involvement with her hand. She also developed right paresthesia on the sole of her foot which lasted a couple of days. She states she has never experienced the hand thing completely, for such an extensive time. She has experienced stuff before, but milder. She has never had paresthesia in 2 different places. It seems she was experiencing shock-like symptoms in both hands, that lasted about a week. She did have a neurologic assessment, just as exam, not a testing. But, she confirms the testing was fine. She experienced re-occurring paresthesia in her left hand this morning, but it was after sleeping with her neck completely craned. Caller stated she doesn't know if its vaccine related. Also, her second vaccine is due this week and she doesn't want it be worse. The outcome of event shock-like symptoms in both hands was recovered on 02Jan2021. The outcome of event paresthesia in the fingers of her left hand/right paresthesia on the sole of her foot was recovered. The outcome of other events was unknown. Information about Lot/Batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported "shock-like symptoms" cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm